©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 104349
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.104349
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.104349
Table 4 Donor-derived cell-free DNA values in different conditions affecting the transplanted kidney
| Conditions | dd-cfDNA values |
| Mixed rejection | 2.85% ± 0.68% |
| Acute TCMR | 2.03% ± 1.13% |
| Active ABMR | 1.15% ± 0.15% |
| Chronic active ABMR | 1.09% ± 0.15% |
| Chronic active TCMR | 0.59% ± 0.17% |
| BKV associated nephropathy | 0.44% ± 0.06% |
| FSGS | 0.40% ± 0.06% |
| Glomerulitis without rejection | 0.45% ± 0.06% |
| Isolated IFTA | 0.36% ± 0.02% |
- Citation: Salvadori M, Rosso G. Utility and limitations of the use of donor-derived cell-free DNA in kidney transplantation. World J Transplant 2025; 15(4): 104349
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/104349.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.104349